These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1903945)

  • 41. 9-Deazaguanine derivatives: synthesis and inhibitory properties as multi-substrate analogue inhibitors of mammalian PNPs.
    Yatsu T; Hashimoto M; Hikishima S; Magnowska L; Bzowska A; Yokomatsu T
    Nucleic Acids Symp Ser (Oxf); 2008; (52):661-2. PubMed ID: 18776553
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rabbit erythrocyte purine nucleoside phosphorylase. Differential-inactivation studies.
    Savage B; Spencer N
    Biochem J; 1979 Apr; 179(1):29-34. PubMed ID: 112995
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Purine nucleoside phosphorylase inhibitors: biochemical and pharmacological studies with 9-benzyl-9-deazaguanine and related compounds.
    Bennett LL; Allan PW; Noker PE; Rose LM; Niwas S; Montgomery JA; Erion MD
    J Pharmacol Exp Ther; 1993 Aug; 266(2):707-14. PubMed ID: 8355201
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Formycins A and B and some analogues: selective inhibitors of bacterial (Escherichia coli) purine nucleoside phosphorylase.
    Bzowska A; Kulikowska E; Shugar D
    Biochim Biophys Acta; 1992 Apr; 1120(3):239-47. PubMed ID: 1576149
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nicotinamide riboside, an unusual, non-typical, substrate of purified purine-nucleoside phosphorylases.
    Wielgus-Kutrowska B; Kulikowska E; Wierzchowski J; Bzowska A; Shugar D
    Eur J Biochem; 1997 Jan; 243(1-2):408-14. PubMed ID: 9030766
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fluorescence studies of calf spleen purine nucleoside phosphorylase (PNP) complexes with guanine and 9-deazaguanine.
    Stepniak K; Zinić B; Wierzchowski J; Bzowska A
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(6-7):841-7. PubMed ID: 18066911
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pyrrolo[3,2-d]pyrimidines, a new class of purine nucleoside phosphorylase (PNP) inhibitors as potential T-cell selective immunosuppressive agents.
    Sircar JC; Kostlan CR; Gilbertsen RB; Dong MK; Cetenko WA
    Adv Exp Med Biol; 1991; 309A():45-8. PubMed ID: 1789265
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative in vitro and in vivo activities of two 9-deazaguanine analog inhibitors of purine nucleoside phosphorylase, CI-972 and PD 141955.
    Gilbertsen RB; Josyula U; Sircar JC; Dong MK; Wu WS; Wilburn DJ; Conroy MC
    Biochem Pharmacol; 1992 Sep; 44(5):996-9. PubMed ID: 1530667
    [TBL] [Abstract][Full Text] [Related]  

  • 49. 2-Chloro-2'-deoxyadenosine (cladribine) and its analogues are good substrates and potent selective inhibitors of Escherichia coli purine-nucleoside phosphorylase.
    Bzowska A; Kazimierczuk Z
    Eur J Biochem; 1995 Nov; 233(3):886-90. PubMed ID: 8521855
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and evaluation of 9-deazaguanine derivatives as multi-substrate analogue inhibitors of PNP.
    Hashimoto M; Hikishima S; Magnowska L; Bzowska A; Yokomatsu T
    Nucleic Acids Symp Ser (Oxf); 2007; (51):431-2. PubMed ID: 18029771
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and biological evaluation of 9-(5',5'-difluoro-5'-phosphonopentyl)guanine derivatives for PNP-inhibitors.
    Hikishima S; Isobe M; Koyanagi S; Soeda S; Shimeno H; Shibuya S; Yokomatsu T
    Bioorg Med Chem; 2006 Mar; 14(5):1660-70. PubMed ID: 16263289
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Crystal structure of calf spleen purine nucleoside phosphorylase in a complex with hypoxanthine at 2.15 A resolution.
    Koellner G; Luić M; Shugar D; Saenger W; Bzowska A
    J Mol Biol; 1997 Jan; 265(2):202-16. PubMed ID: 9020983
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design of purine nucleoside phosphorylase inhibitors.
    Stoeckler JD; Ealick SE; Bugg CE; Parks RE
    Fed Proc; 1986 Nov; 45(12):2773-8. PubMed ID: 3095150
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human erythrocytic purine nucleoside phosphorylase: reaction with sugar-modified nucleoside substrates.
    Stoeckler JD; Cambor C; Parks RE
    Biochemistry; 1980 Jan; 19(1):102-7. PubMed ID: 6766310
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 1-Azaribofuranoside analogues as designed inhibitors of purine nucleoside phosphorylase. Synthesis and biological evaluation.
    Hansen SU; Bols M
    Acta Chem Scand (Cph); 1998 Oct; 52(10):1214-22. PubMed ID: 9785443
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synthesis of novel nucleotide analogues possessing a difluoromethylenephosphonato group. Evaluation of the inhibitory activity for purine nucleoside phosphorylase.
    Yokomatsu T; Hayakawa Y; Abe H; Shibuya S; Kihara T; Soeda S; Shimeno H
    Nucleic Acids Symp Ser; 1999; (42):27-8. PubMed ID: 10780362
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Structure-based design of inhibitors of purine nucleoside phosphorylase. 1. 9-(arylmethyl) derivatives of 9-deazaguanine.
    Montgomery JA; Niwas S; Rose JD; Secrist JA; Babu YS; Bugg CE; Erion MD; Guida WC; Ealick SE
    J Med Chem; 1993 Jan; 36(1):55-69. PubMed ID: 8421291
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exploring structure-activity relationships of transition state analogues of human purine nucleoside phosphorylase.
    Evans GB; Furneaux RH; Lewandowicz A; Schramm VL; Tyler PC
    J Med Chem; 2003 Jul; 46(15):3412-23. PubMed ID: 12852771
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Crystal structure of the purine nucleoside phosphorylase (PNP) from Cellulomonas sp. and its implication for the mechanism of trimeric PNPs.
    Tebbe J; Bzowska A; Wielgus-Kutrowska B; Schröder W; Kazimierczuk Z; Shugar D; Saenger W; Koellner G
    J Mol Biol; 1999 Dec; 294(5):1239-55. PubMed ID: 10600382
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antiproliferative activity of purine nucleoside phosphorylase multisubstrate analogue inhibitors containing difluoromethylene phosphonic acid against leukaemia and lymphoma cells.
    Glavas-Obrovac L; Suver M; Hikishima S; Hashimoto M; Yokomatsu T; Magnowska L; Bzowska A
    Chem Biol Drug Des; 2010 Apr; 75(4):392-9. PubMed ID: 20102369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.